Norway· NO-ID_BF6084CD-3A53-4DB5-B9E0-36461FAED2BC
Ontozry
A cenobamate product containing cenobamate, registered in Norway by Angelini Pharma S.p.A.. The same ATC class is registered in 15 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Cenobamate is registered in 15 of 19 countries.
Countries holding a registration under ATC N03AX25 (cenobamate), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 10 of them publish a price we can compare per daily dose
Cenobamate · ATC N03AX25
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cenobamate costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), the median price runs from $4.11 in France to $21.72 in Switzerland — a ×5.3 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cenobamate · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$21.72
- IT Italy$19.89
- CZ Czechia$4.12
- FR France$4.11
The record
At a glance
FEST (Norway)- Active substance
- Cenobamate
- Manufacturer
- Angelini Pharma S.p.A.
- Country
- Norway (NO)
- ATC code
- N03AX25
- ATC class
- Cenobamate
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 5
2 priced- no_merkevare_idID_BF6084CD-3A53-4DB5-B9E0-36461FAED2BC
- no_varenummer37107714NOK 869
- no_varenummer17496428NOK 1735.6
- gtin8000036027950
- gtin8000036027967
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
273 interactions on record for cenobamate.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cenobamate · interactions on record
273 records
- 29 severe
- 237 moderate
- 7 minor
Most severe, free to view
- DeflazacortH02AB13severe
- BosutinibL01EA04severe
- EncorafenibL01EC03severe
- BrigatinibL01ED04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cenobamate in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandOntozryParanova Oy
- SwitzerlandOntozry 150 mg, FilmtablettenAngelini Pharma S.p.A., Rom, Zweigniederlassung Zug
- CzechiaONTOZRYAngelini Pharma S.p.A, Rome
- SpainONTOZRY 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULAAngelini Pharma Italia Aziende Chimiche Riunite Angelini Francesc O A.C.R.A.F. S.P.A. Enunciabile An
- United StatesXcopriSK Life Science, Inc.
- PolandOntozryAngelini Pharma S.p.A.
- SwedenOntozry 150 mg Filmdragerad tablettAngelini Pharma S.p.A.
- IrelandOntozry 150 mg film-coated tabletsAngelini Pharma Italia S.P.A.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Ontozry
- Liechtenstein · Ontozry
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b445fef7-e8eb-472c-af2b-ce969319851e GET /v1/drugs/b445fef7-e8eb-472c-af2b-ce969319851e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett, filmdrasjert",
"source": "fest",
"status": "A",
"atc_name": "Senobamat",
"merkevare_id": "ID_BF6084CD-3A53-4DB5-B9E0-36461FAED2BC",
"name_form_strength": "Ontozry tab 150 mg",
"prescription_group": "C"
}See everything about cenobamate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.